Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1984-11-28
pubmed:abstractText
Using the technique of microelectrophoresis in pentobarbitone-anaesthetized cats and rats, the effects of benzomorphans, with known actions at sigma- and kappa- opioid receptors, were tested on responses of spinal neurones to amino acids and acetylcholine. The racemic mixture and both enantiomers of the sigma opiate receptor agonist, N-allylnormetazocine (SKF 10, 047), and the dissociative anaesthetic, ketamine, reduced or abolished excitation evoked by N-methyl-aspartate (NMA) with only small and variable effects on responses to quisqualate or kainate. (+)-SKF 10, 047 was 1.2 +/- 0.7 times more potent than the (-)-enantiomer in antagonizing NMA. On Renshaw cells, (+)-SKF 10, 047 enhanced responses to acetylcholine whereas the (-) enantiomer produced only a small reduction. The kappa- opiate receptor agonist, ethylketocyclazocine, had no selective effects on responses to amino acids or to acetylcholine. We conclude that actions at sigma- but not kappa-, opiate receptors are responsible for the NMA antagonism observed with benzomorphans.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/6091823-291953, http://linkedlifedata.com/resource/pubmed/commentcorrection/6091823-42459, http://linkedlifedata.com/resource/pubmed/commentcorrection/6091823-6101908, http://linkedlifedata.com/resource/pubmed/commentcorrection/6091823-6112965, http://linkedlifedata.com/resource/pubmed/commentcorrection/6091823-6124634, http://linkedlifedata.com/resource/pubmed/commentcorrection/6091823-6126548, http://linkedlifedata.com/resource/pubmed/commentcorrection/6091823-6131363, http://linkedlifedata.com/resource/pubmed/commentcorrection/6091823-6264253, http://linkedlifedata.com/resource/pubmed/commentcorrection/6091823-6272083, http://linkedlifedata.com/resource/pubmed/commentcorrection/6091823-6272322, http://linkedlifedata.com/resource/pubmed/commentcorrection/6091823-6290235, http://linkedlifedata.com/resource/pubmed/commentcorrection/6091823-6299772, http://linkedlifedata.com/resource/pubmed/commentcorrection/6091823-6308211, http://linkedlifedata.com/resource/pubmed/commentcorrection/6091823-6373309, http://linkedlifedata.com/resource/pubmed/commentcorrection/6091823-6834266, http://linkedlifedata.com/resource/pubmed/commentcorrection/6091823-6875963, http://linkedlifedata.com/resource/pubmed/commentcorrection/6091823-7044685, http://linkedlifedata.com/resource/pubmed/commentcorrection/6091823-7048142, http://linkedlifedata.com/resource/pubmed/commentcorrection/6091823-7109842, http://linkedlifedata.com/resource/pubmed/commentcorrection/6091823-7402442, http://linkedlifedata.com/resource/pubmed/commentcorrection/6091823-945347
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Acetylcholine, http://linkedlifedata.com/resource/pubmed/chemical/Amino Acids, http://linkedlifedata.com/resource/pubmed/chemical/Aspartic Acid, http://linkedlifedata.com/resource/pubmed/chemical/Cyclazocine, http://linkedlifedata.com/resource/pubmed/chemical/Ethylketocyclazocine, http://linkedlifedata.com/resource/pubmed/chemical/Kainic Acid, http://linkedlifedata.com/resource/pubmed/chemical/Ketamine, http://linkedlifedata.com/resource/pubmed/chemical/Ligands, http://linkedlifedata.com/resource/pubmed/chemical/N-Methylaspartate, http://linkedlifedata.com/resource/pubmed/chemical/Oxadiazoles, http://linkedlifedata.com/resource/pubmed/chemical/Phenazocine, http://linkedlifedata.com/resource/pubmed/chemical/Quisqualic Acid, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Opioid, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Opioid, kappa, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, sigma, http://linkedlifedata.com/resource/pubmed/chemical/SK&F 10047
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0007-1188
pubmed:author
pubmed:issnType
Print
pubmed:volume
83
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
179-85
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:6091823-Acetylcholine, pubmed-meshheading:6091823-Amino Acids, pubmed-meshheading:6091823-Animals, pubmed-meshheading:6091823-Aspartic Acid, pubmed-meshheading:6091823-Cats, pubmed-meshheading:6091823-Cyclazocine, pubmed-meshheading:6091823-Ethylketocyclazocine, pubmed-meshheading:6091823-Kainic Acid, pubmed-meshheading:6091823-Ketamine, pubmed-meshheading:6091823-Ligands, pubmed-meshheading:6091823-Microelectrodes, pubmed-meshheading:6091823-N-Methylaspartate, pubmed-meshheading:6091823-Neurons, pubmed-meshheading:6091823-Oxadiazoles, pubmed-meshheading:6091823-Phenazocine, pubmed-meshheading:6091823-Quisqualic Acid, pubmed-meshheading:6091823-Rats, pubmed-meshheading:6091823-Receptors, Opioid, pubmed-meshheading:6091823-Receptors, Opioid, kappa, pubmed-meshheading:6091823-Receptors, sigma, pubmed-meshheading:6091823-Stereoisomerism
pubmed:year
1984
pubmed:articleTitle
Comparison of sigma- and kappa-opiate receptor ligands as excitatory amino acid antagonists.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't